mafosfamide has been researched along with Graft-Versus-Host Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carreras, E; Diaz-Ricart, M; Escolar, G; Martinez-Sanchez, J; Moreno-Castaño, AB; Palomo, M; Pascual-Diaz, R; Rovira, M; Salas, MQ; Ventosa, H | 1 |
| Nusair, S; Reich, S; Sidi, H; Slavin, S; Weiss, L | 1 |
| Carella, AM; Carlo-Stella, C; Mangoni, L; Rizzoli, V | 1 |
| Kohn, FR; Sladek, NE | 1 |
1 trial(s) available for mafosfamide and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cyclosporins; Female; Graft vs Host Disease; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous | 1990 |
3 other study(ies) available for mafosfamide and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro.
Topics: Cyclophosphamide; Cyclosporine; Endothelial Cells; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Proto-Oncogene Proteins c-akt; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2023 |
Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
Topics: Adjuvants, Immunologic; Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Disease Models, Animal; Graft vs Host Disease; Immunotherapy, Adoptive; Interleukin-2; Leukemia, B-Cell; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Spleen; T-Lymphocytes | 1996 |
Ex vivo treatment of murine splenocyte-supplemented bone marrow inocula with mafosfamide prior to allogeneic transplantation in an attempt to prevent lethal graft-versus-host disease without compromising engraftment.
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Graft Survival; Graft vs Host Disease; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Spleen; T-Lymphocytes | 1988 |